Literature DB >> 18392157

Comparison of the predictive validity of hyperkinetic disorder and attention deficit hyperactivity disorder.

Russell Schachar1, Shirley Chen, Jennifer Crosbie, Lisa Goos, Abel Ickowicz, Alice Charach.   

Abstract

INTRODUCTION: We compared the predictive validity of attention deficit hyperactivity disorder (ADHD; Diagnostic and Statistical Manual - IV Edition) and hyperkinetic disorder (HKD; International Classification of Diseases - 10th Edition) while controlling for the presence of comorbid psychopathology.
METHOD: ADHD and HKD criteria were used to classify 804 clinic-referred children ages 6 to 16 years into one of four non-overlapping groups: HKD, ADHD combined subtype (ADHD-C), ADHD hyper-active-impulsive subtype (ADHD-HI), ADHD inattentive subtype (ADHD-IA). Groups were compared with each other and with normal controls (67) while controlling for age and intelligence on a range of criteria both before and after excluding cases with comorbidity.
RESULTS: Of the 804 clinic participants, 72 (8.9 %) met criteria for ICD-10 HKD, 353 (43.9 %) for ADHD-C, 142 (17.7 %) for ADHD-HI and 237 (29.5 %) for ADHD-IA. There were no differences among the four clinic groups in rate of comorbidity, neuro-developmental or psychosocial risk indices, inter-parental or parent-child discord, family history of ADHD, working memory, and academic or intelligence test scores, but all clinic groups differed from normal controls. By contrast, total number of symptoms, teacher-rated impairment and inhibitory control deficit were greatest in HKD and least in ADHD-C, ADHD-HI, ADHD-IA in that order. Results of the comparisons were essentially unchanged after excluding cases (75%) with a comorbid condition.
CONCLUSIONS: HKD, ADHD-C, ADHD-HI and ADHD-IA had approximately equivalent predictive validity even when comorbidity was taken into account.

Entities:  

Keywords:  ADHD subtypes; DSM-IV; ICD-10; attention-deficit hyperactivity disorder; hyperkinetic disorder

Year:  2007        PMID: 18392157      PMCID: PMC2242647     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN: 1719-8429


  19 in total

Review 1.  ADHD is best understood as a cultural construct.

Authors:  Sami Timimi; Eric Taylor
Journal:  Br J Psychiatry       Date:  2004-01       Impact factor: 9.319

2.  Experimental cross-validation of DSM-IV types of attention-deficit/hyperactivity disorder.

Authors:  K McBurnett; L J Pfiffner; E Willcutt; L Tamm; M Lerner; Y L Ottolini; M B Furman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-01       Impact factor: 8.829

3.  Clinical guidelines for hyperkinetic disorder. European Society for Child and Adolescent Psychiatry.

Authors:  E Taylor; J Sergeant; M Doepfner; B Gunning; S Overmeyer; H J Möbius; H G Eisert
Journal:  Eur Child Adolesc Psychiatry       Date:  1998-12       Impact factor: 4.785

Review 4.  Genetic basis of attention deficit and hyperactivity.

Authors:  A Thapar; J Holmes; K Poulton; R Harrington
Journal:  Br J Psychiatry       Date:  1999-02       Impact factor: 9.319

Review 5.  Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review.

Authors:  Erik G Willcutt; Alysa E Doyle; Joel T Nigg; Stephen V Faraone; Bruce F Pennington
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

6.  The parent interview for child symptoms: a situation-specific clinical research interview for attention-deficit hyperactivity and related disorders.

Authors:  Abel Ickowicz; Russell J Schachar; Richard Sugarman; Shirley X Chen; Claude Millette; Lisa Cook
Journal:  Can J Psychiatry       Date:  2006-04       Impact factor: 4.356

7.  Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children.

Authors:  Benjamin B Lahey; William E Pelham; Andrea Chronis; Greta Massetti; Heidi Kipp; Ashley Ehrhardt; Steve S Lee
Journal:  J Child Psychol Psychiatry       Date:  2006-05       Impact factor: 8.982

8.  A comparison of the neuropsychological profiles of the DSM-IV subtypes of ADHD.

Authors:  N Chhabildas; B F Pennington; E G Willcutt
Journal:  J Abnorm Child Psychol       Date:  2001-12

9.  The prevalence and co-morbidity of subthreshold psychiatric conditions.

Authors:  Peter M Lewinsohn; Stewart A Shankman; Jeffrey M Gau; Daniel N Klein
Journal:  Psychol Med       Date:  2004-05       Impact factor: 7.723

10.  Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample.

Authors:  M L Wolraich; J N Hannah; A Baumgaertel; I D Feurer
Journal:  J Dev Behav Pediatr       Date:  1998-06       Impact factor: 2.225

View more
  2 in total

1.  Clinical factors associated with decision to recommend methylphenidate treatment for children with ADHD in France.

Authors:  Elodie Courtabessis; Florence Pupier; Laurie Surig; Marie-Christine Picot; Erika Nogué; Valérie Macioce; Elizabeth Stein; Diane Purper-Ouakil
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-05       Impact factor: 4.785

Review 2.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.